Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Yeh

Showing results (701-710 of 837) with videos related to

Pageof 84
Sort By:
Tissue Antigens|April 24, 2004
Polymorphism of HLA-B27 in Taiwanese ChineseK L Yang, I-H Chen, C K Hsiao, et al.
Diseases of the Colon and Rectum|May 2, 2000
Premedication with dextromethorphan provides posthemorrhoidectomy pain reliefS T Liu, C T Wu, C C Yeh, et al.
Journal of Surgical Oncology|December 18, 2001
Liver resection for hepatocellular carcinoma in patients with end-stage renal failureS B Cheng, C C Wu, K H Shu, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|November 17, 2001
Development of a high-performance liquid chromatographic method for bioanalytical applications with sulpirideM C Huang, H O Ho, G C Yeh, et al.
Surgery|April 4, 1998
Hepatic resection for bilobar multicentric hepatocellular carcinoma: is it justified?C C Wu, W L Ho, M C Lin, et al.
Journal of Endocrinological Investigation|July 31, 2020
Parathyroidectomy slows renal function decline in patients with primary hyperparathyroidismC-C Liang, H-C Yeh, Y-C Lo, et al.
Clinical Pharmacology and Therapeutics|September 1, 1981
Effect of antacids on the bioavailability of diflunisal in the fasting and postprandial statesJ A Tobert, P DeSchepper, T B Tjandramaga, et al.
The Journal of Clinical Investigation|October 3, 2001
The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activationC A Cuff, D Kothapalli, I Azonobi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Bioequivalence of 20-mg once-daily tamoxifen relative to 10-mg twice-daily tamoxifen regimens for breast cancerA U Buzdar, G N Hortobagyi, D Frye, et al.
Investigational New Drugs|December 22, 2015
Effect of CH-35, a novel anti-tumor colchicine analogue, on breast cancer cells overexpressing the βIII isotype of tubulinLee-Chuan C Yeh, Asok Banerjee, Veena Prasad, et al.
Pageof 84

Showing results (701-710 of 837) with videos related to

Sort By:
Pageof 84
Tissue Antigens|April 24, 2004
Polymorphism of HLA-B27 in Taiwanese ChineseK L Yang, I-H Chen, C K Hsiao, et al.
Diseases of the Colon and Rectum|May 2, 2000
Premedication with dextromethorphan provides posthemorrhoidectomy pain reliefS T Liu, C T Wu, C C Yeh, et al.
Journal of Surgical Oncology|December 18, 2001
Liver resection for hepatocellular carcinoma in patients with end-stage renal failureS B Cheng, C C Wu, K H Shu, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|November 17, 2001
Development of a high-performance liquid chromatographic method for bioanalytical applications with sulpirideM C Huang, H O Ho, G C Yeh, et al.
Surgery|April 4, 1998
Hepatic resection for bilobar multicentric hepatocellular carcinoma: is it justified?C C Wu, W L Ho, M C Lin, et al.
Journal of Endocrinological Investigation|July 31, 2020
Parathyroidectomy slows renal function decline in patients with primary hyperparathyroidismC-C Liang, H-C Yeh, Y-C Lo, et al.
Clinical Pharmacology and Therapeutics|September 1, 1981
Effect of antacids on the bioavailability of diflunisal in the fasting and postprandial statesJ A Tobert, P DeSchepper, T B Tjandramaga, et al.
The Journal of Clinical Investigation|October 3, 2001
The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activationC A Cuff, D Kothapalli, I Azonobi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Bioequivalence of 20-mg once-daily tamoxifen relative to 10-mg twice-daily tamoxifen regimens for breast cancerA U Buzdar, G N Hortobagyi, D Frye, et al.
Investigational New Drugs|December 22, 2015
Effect of CH-35, a novel anti-tumor colchicine analogue, on breast cancer cells overexpressing the βIII isotype of tubulinLee-Chuan C Yeh, Asok Banerjee, Veena Prasad, et al.
Pageof 84